Global Contrast Media Market – Analysis and Forecast (2022-2030)

Industry Insight by Media Type (Iodinated Contrast Media, Gadolinium-Based Contrast Media, Microbubble Contrast Media, Barium-Based Contrast Media, and Others), by Indication (Cardiovascular Disorders, Cancer, Gastrointestinal Disorders, Musculoskeletal Disorders, Neurological Disorders, and Nephrological Disorders), by Modality (X-Ray, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Catheterization Laboratory, Ultrasound, and Others), by Route of Administration (Intravascular Route, Oral Route, Rectal Route, and Others), by Application (Radiology, Interventional Radiology, and Interventional Cardiology), and Geography (U.S., Canada, Germany, U.K., France, China, Japan, India, and Rest of the World)

Industry Overview

The global contrast media market size was valued at USD 4.75 billion in 2021 and is expected to reach USD 8.5 billion by 2030. During the forecast period, it is expected to grow at a CAGR of 4.2%. Contrast media or contrast agent alters the way medical imaging equipment interacts with the body and allows certain parts of the body to be distinguished from surrounding tissue. It aids in the visibility of blood arteries, specific tissues, and organs. Contrast media/contrast agents improve internal body images obtained during ultrasound, X-ray, MRI, and CT scans. It assists radiologists in distinguishing between abnormal and normal tissues.

Following the pandemic, the market for Contrast Media/Contrast Agent in healthcare is expected to skyrocket. The advent of digital solutions for accurate and efficient management of contrast agent injection and increasing incidences of heart attack and strokes have bolstered the market development of the contrast media market during the Post Covid-19 outbreak.

Market Segmentation

Insight by Media Type

Based on Media Type, the Global Contrast Media Market is segmented into Iodinated Contrast Media, Gadolinium-Based Contrast Media, Microbubble Contrast Media, Barium-Based Contrast Media, and Others. The Iodinated Contrast Media segment is poised to have the largest market share due to the widespread use of X-ray and CT procedures and the availability of non-ionically stable iodinated agents for advanced diagnosis. A form of intravenous radio contrast (radiographic dye) called iodinated contrast medium contains iodine and aids in improving the visibility of vascular systems and organs during radiographic procedures. The visibility of disorders like cancer diagnosis has improved because of the iodinated contrast. Moreover, the expansion is a result of the increased radio-opacity and lower toxicity of iodine-based contrast media compared to other agents. Almost all radiological tests that use injectable contrast media use iodinated contrast media.

Insight by Indication

Based on Indication, the Global Contrast Media Market is divided into Cardiovascular Disorders, Cancer, Gastrointestinal Disorders, Musculoskeletal Disorders, Neurological Disorders, and Nephrological Disorders. Cardiovascular Disorders are expected to dominate the market owing to the mounting geriatric population suffering from CVD globally. Additionally, the market is expanding as a result of an increase in the need for image-guided procedures and diagnostics, an increase in the prevalence and mortality of cardiac ailments, and technical advancements in the medical imaging sector.

Insight by Modality

Based on Modality, the Global Contrast Media Market is segregated into X-Ray, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Catheterization Laboratory, Ultrasound, and Others. Among these, X-ray/CT contrast agents aid in the generation of high-resolution 3D images of structures. In X-ray and CT techniques, barium-based and iodinated contrast agents are used. When barium and iodine contrast agents are injected into the body, they block X-rays and prevent them from passing through. As a result, organs, blood vessels, and other body tissues containing barium-based or iodinated contrast media temporarily change appearance. X-ray and CT scans are widely used in a variety of diseases and are expected to drive market growth.

Insight on Route of Administration

Based on the Route of Administration, the Global Contrast Media Market is fragmented into Intravascular Route, Oral Route, Rectal Route, and Others. The oral route contributes the largest share in the market owing to ease of use and is mostly deployed in abdominal and pelvic CT scans.

Insight by Application            

Based on Application, the Global Contrast Media Market is segmented into Radiology, Interventional Radiology, and Interventional Cardiology. Interventional Cardiology is expected to contribute the largest share of the market owing to a mounting number of people suffering from heart disorders and an increased geriatric population globally.

Global Contrast Media Market Report Coverage

Industry Dynamics

Growth Drivers

Factors attributing to the market growth of the contrast media market include the rising number of diagnostic procedures, mounting prominence of minimally invasive techniques, increased incidences of infectious diseases with multiple comorbidities, increasing sanctions of contrast agents, and availability of reimbursement policies, thereby driving the market expansion of contrast media industry. The growing use of medical imaging is driving up demand for contrast media and boosting revenue growth in the Contrast Media market. Thus, contrast media improves the quality of scan images by diagnosing chronic diseases through scans like X-rays, MRI, and CT scans. This in turn will help doctors to determine the precise treatment and cure or diminish the disorder.

Challenges

The global contrast media market growth is projected to be hampered by the high price of contrast media injectors, the mild and adverse side effects of contrast media like vomiting, bluish skin color, stomach cramps, etc., and a lack of qualified professionals to operate the newest imaging technology. Also, it is anticipated that the need for contrast media will be constrained in the future due to the dearth of sophisticated diagnostic techniques in many developing countries.

Opportunities

The increased research and development on contrast agents, development of novel applications, rising governmental and private sector investments as well as increased focus on developing affordable contrast media are creating promising opportunities for growth in the global contrast media industry.

Due to the patent expiration of branded contrast media products, competition in the contrast media market is expected to increase significantly in the coming years. This will open up opportunities for generic counterparts to enter the market, which are less expensive than commercially available branded agents.

Geographic Overview

• North America
• Europe
• Asia Pacific (APAC)
• Rest of the World (RoW)

North America dominates the contrast media market owing to a surge in demand for early diagnosis, upsurging technological development in diagnostic imaging systems, increasing volume of CT and MRI examinations, mounting geriatric population suffering from chronic diseases, and increased initiatives by the government in the field of medical imaging.

Asia-Pacific is expected to have a high CAGR during the forecast period owing to an increased number of MRI and CT scan procedures, the presence of developed cath labs, and the mounting prominence of cardiac disorders.

Competitive Insight

The industry players use strategies such as M&A, product launch, contractual agreements, collaborations, and indication expansion. Acquisitions help businesses expand their geographic reach and strengthen their portfolios. Disease indication extension is popular in this market because it allows firms to gain the trust of specific population subsets. Companies target niche patient cohorts and increase product adoption with approvals for specific indications. Also, the key players should adopt cost-effective techniques to diversify and survive in the competitive market environment.

GE Healthcare is committed to offer a broad and comprehensive portfolio of Contrast Media products that assist in meeting patient and procedural needs across a wide range of modalities. GE Healthcare has a long history of developing contrast media. Their diverse portfolio includes X-ray/CT, MRI, and Ultrasound modalities. GE Healthcare already has the world's largest X-ray API manufacturing facility, supplying one-third of the global market supply for contrast media. They collaborate with multiple suppliers to help ensure the security of iodine supply, allowing them to confidently schedule procedures. Working with GE Healthcare as a contrast media supplier across multiple modalities may enable simplification and the potential for time savings in administration.

Bayer offers an exhaustive portfolio of contrast media for CT scan, X-Ray, and magnetic resonance imaging (MRI) devices, as well as informatics solutions and a medical imaging platform that provides access to applications, including those powered by AI. Bayer's radiology portfolio includes everything from contrast media to devices that help radiologists in their mission to help patients suffering from cardiovascular disease with early diagnosis and targeted treatment.

Recent Development by Key Players

GE Healthcare has pledged to boost the production of iodinated contrast media, which is frequently used in computed tomography and X-Ray Imaging, by 30 million yearly by 2025. To this end, the company entered into a multi-year partnership in October 2022, with Sociedad Quimica y Minera de Chile S.A. (SQM), a mining company in Chile, thereby increasing the supply of raw iodine.

Bracco Diagnostics Inc., a U.S. subsidiary of Bracco Imaging S.p.A., announced on July 27, 2022 from its headquarters in Milan, Italy, that the U.S. Food and Drug Administration (FDA) has granted import discretion of Iomeron (iomeprol injection) into the U.S. to resolve the continuing iodinated contrast media shortage.

Key Players Covered in the Report

Some of the major players operating in the contrast media market include GE HealthCare, Bracco, Bayer AG, Guerbet, DAIICHI SANKYO COMPANY, LIMITED, Lantheus, TAEJOON PHARM, Magnus Health, Nano THERAPEUTICS PVT.LTD., and Trivitron Healthcare.

The Contrast Media Market report offers a comprehensive market segmentation analysis along with an estimation for the forecast period 2022–2030.

Segments Covered in the Report

• By Media Type
  • Iodinated Contrast Media
  • Gadolinium-Based Contrast Media
  • Microbubble Contrast Media
  • Barium-Based Contrast Media
  • Others
• By Indication
  • Cardiovascular Disorders
  • Cancer
  • Gastrointestinal Disorders
  • Musculoskeletal Disorders
  • Neurological Disorders
  • Nephrological Disorders
• By Modality
  • X-Ray
  • Computed Tomography (CT)
  • Magnetic Resonance Imaging (MRI)
  • Catheterization Laboratory
  • Ultrasound
  • Others
• By Route of Administration
  • Intravascular Route
  • Oral Route
  • Rectal Route
  • Others
• By Application
  • Radiology
  • Interventional Radiology
  • Interventional Cardiology

Region Covered in the Report

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia-Pacific (APAC)
  • China
  • Japan
  • India
  • South Korea
  • Rest of Asia-Pacific
• Rest of the World (RoW)
  • Brazil
  • Saudi Arabia
  • South Africa
  • U.A.E.
  • Other Countries

To explore more about this report - Request a free sample copy

1.    Research Overview

        1.1.    The Report Offers
        1.2.    Market Coverage
                1.2.1.    By Media Type
                1.2.2.    By Indication
                1.2.3.    By Modality
                1.2.4.    By Route of Administration
                1.2.5.    By Application
                1.2.6.    By Region
        1.3.    Research Phases
        1.4.    Limitations
        1.5.    Market Methodology
                1.5.1.    Data Sources
                        1.5.1.1. Primary Research
                        1.5.1.2. Secondary Research
                1.5.2.    Methodology
                        1.5.2.1. Data Exploration
                        1.5.2.2. Forecast Parameters
                        1.5.2.3. Data Validation
                        1.5.2.4. Assumptions
                1.5.3.    Study Period & Data Reporting Unit

2.    Executive Summary

3.    Industry Overview

        3.1.    Industry Dynamics
                3.1.1.    Market Growth Drivers
                3.1.2.    Market Restraints
                3.1.3.    Key Market Trends
                3.1.4.    Major Opportunities
        3.2.    Industry Ecosystem
                3.2.1.    Porter’s Five Forces Analysis
                3.2.2.    Recent Development Analysis
                3.2.3.    Value Chain Analysis
        3.3.    Competitive Insight
                3.3.1.    Competitive Position of Industry Players
                3.3.2.    Market Attractive Analysis
                3.3.3.    Market Share Analysis

4.    Global Market Estimate and Forecast

        4.1.    Global Market Overview
        4.2.    Global Market Estimate and Forecast to 2030

5.    Market Segmentation Estimate and Forecast

        5.1.    By Media Type
                5.1.1.    Iodinated Contrast Media
                        5.1.1.1. Market Definition
                        5.1.1.2. Market Estimation and Forecast to 2030 
                5.1.2.    Gadolinium-Based Contrast Media
                        5.1.2.1. Market Definition
                        5.1.2.2. Market Estimation and Forecast to 2030
                5.1.3.    Microbubble Contrast Media
                        5.1.3.1. Market Definition
                        5.1.3.2. Market Estimation and Forecast to 2030
                5.1.4.    Barium-Based Contrast Media
                        5.1.4.1. Market Definition
                        5.1.4.2. Market Estimation and Forecast to 2030
                5.1.5.    Others
                        5.1.5.1. Market Definition
                        5.1.5.2. Market Estimation and Forecast to 2030
        5.2.    By Indication
                5.2.1.    Cardiovascular Disorders
                        5.2.1.1. Market Definition
                        5.2.1.2. Market Estimation and Forecast to 2030
                5.2.2.    Cancer
                        5.2.2.1. Market Definition
                        5.2.2.2. Market Estimation and Forecast to 2030
                5.2.3.    Gastrointestinal Disorders
                        5.2.3.1. Market Definition
                        5.2.3.2. Market Estimation and Forecast to 2030
                5.2.4.    Musculoskeletal Disorders
                        5.2.4.1. Market Definition
                        5.2.4.2. Market Estimation and Forecast to 2030
                5.2.5.    Neurological Disorders
                        5.2.5.1. Market Definition
                        5.2.5.2. Market Estimation and Forecast to 2030
                5.2.6.    Nephrological Disorders
                        5.2.6.1. Market Definition
                        5.2.6.2. Market Estimation and Forecast to 2030
        5.3.    By Modality
                5.3.1.    X-Ray
                        5.3.1.1. Market Definition
                        5.3.1.2. Market Estimation and Forecast to 2030
                5.3.2.    Computed Tomography (CT)
                        5.3.2.1. Market Definition
                        5.3.2.2. Market Estimation and Forecast to 2030
                5.3.3.    Magnetic Resonance Imaging (MRI)
                        5.3.3.1. Market Definition
                        5.3.3.2. Market Estimation and Forecast to 2030
                5.3.4.    Catheterization Laboratory
                        5.3.4.1. Market Definition
                        5.3.4.2. Market Estimation and Forecast to 2030
                5.3.5.    Ultrasound
                        5.3.5.1. Market Definition
                        5.3.5.2. Market Estimation and Forecast to 2030
                5.3.6.    Others
                        5.3.6.1. Market Definition
                        5.3.6.2. Market Estimation and Forecast to 2030
        5.4.    By Route of Administration
                5.4.1.    Intravascular Route
                        5.4.1.1. Market Definition
                        5.4.1.2. Market Estimation and Forecast to 2030
                5.4.2.    Oral Route
                        5.4.2.1. Market Definition
                        5.4.2.2. Market Estimation and Forecast to 2030
                5.4.3.    Rectal Route
                        5.4.3.1. Market Definition
                        5.4.3.2. Market Estimation and Forecast to 2030
                5.4.4.    Others
                        5.4.4.1. Market Definition
                        5.4.4.2. Market Estimation and Forecast to 2030
        5.5.    By Application
                5.5.1.    Radiology
                        5.5.1.1. Market Definition
                        5.5.1.2. Market Estimation and Forecast to 2030
                5.5.2.    Interventional Radiology
                        5.5.2.1. Market Definition
                        5.5.2.2. Market Estimation and Forecast to 2030
                5.5.3.    Interventional Cardiology
                        5.5.3.1. Market Definition
                        5.5.3.2. Market Estimation and Forecast to 2030            
            
6.    North America Market Estimate and Forecast

        6.1.    By Media Type
        6.2.    By Indication
        6.3.    By Modality
        6.4.    By Route of Administration
        6.5.    By Application
        6.6.    By Country
                6.6.1.    U.S. Market Estimate and Forecast
                6.6.2.    Canada Market Estimate and Forecast
                6.6.3.    Mexico Market Estimate and Forecast

7.    Europe Market Estimate and Forecast

        7.1.    By Media Type
        7.2.    By Indication
        7.3.    By Modality
        7.4.    By Route of Administration
        7.5.    By Application
        7.6.    By Country
                7.6.1.    Germany Market Estimate and Forecast
                7.6.2.    France Market Estimate and Forecast
                7.6.3.    U.K. Market Estimate and Forecast
                7.6.4.    Italy Market Estimate and Forecast
                7.6.5.    Spain Market Estimate and Forecast
                7.6.6.    Rest of Europe Market Estimate and Forecast

8.    Asia-Pacific Market Estimate and Forecast

        8.1.    By Media Type
        8.2.    By Indication
        8.3.    By Modality
        8.4.    By Route of Administration
        8.5.    By Application
        8.6.    By Country
                8.6.1.    China Market Estimate and Forecast
                8.6.2.    Japan Market Estimate and Forecast
                8.6.3.    India Market Estimate and Forecast
                8.6.4.    South Korea Market Estimate and Forecast
                8.6.5.    Singapore Market Estimate and Forecast
                8.6.6.    Rest of Asia-Pacific Market Estimate and Forecast

9.    Rest of the World (RoW) Market Estimate and Forecast

        9.1.    By Media Type
        9.2.    By Indication
        9.3.    By Modality
        9.4.     By Route of Administration
        9.5.     By Application
        9.6.     By Country
                9.6.1.    Brazil Market Estimate and Forecast
                9.6.2.    Saudi Arabia Market Estimate and Forecast
                9.6.3.    South Africa Market Estimate and Forecast
                9.6.4.    Other Countries Market Estimate and Forecast

10.    Company Profiles

        10.1.     GE HealthCare
                10.1.1.    Snapshot
                10.1.2.    Overview
                10.1.3.    Offerings
                10.1.4.    Financial Insight
                10.1.5.    Recent Developments
        10.2.     Bracco
                10.2.1.    Snapshot
                10.2.2.    Overview
                10.2.3.    Offerings
                10.2.4.    Financial Insight
                10.2.5.    Recent Developments
        10.3.Bayer AG
                10.3.1.    Snapshot
                10.3.2.    Overview
                10.3.3.    Offerings
                10.3.4.    Financial Insight
                10.3.5.    Recent Developments
        10.4.Guerbet
                10.4.1.    Snapshot
                10.4.2.    Overview
                10.4.3.    Offerings
                10.4.4.    Financial Insight
                10.4.5.    Recent Developments
        10.5. DAIICHI SANKYO COMPANY, LIMITED
                10.5.1.    Snapshot
                10.5.2.    Overview
                10.5.3.    Offerings
                10.5.4.    Financial Insight
                10.5.5.    Recent Developments
        10.6. Lantheus
                10.6.1.    Snapshot
                10.6.2.    Overview
                10.6.3.    Offerings
                10.6.4.    Financial Insight
                10.6.5.    Recent Developments
        10.7.    TAEJOON PHARM
                10.7.1.    Snapshot
                10.7.2.    Overview
                10.7.3.    Offerings
                10.7.4.    Financial Insight
                10.7.5.    Recent Developments
        10.8.    Magnus Health
                10.8.1.    Snapshot
                10.8.2.    Overview
                10.8.3.    Offerings
                10.8.4.    Financial Insight
                10.8.5.    Recent Developments
        10.9.    Nano THERAPEUTICS PVT.LTD.
                10.9.1.    Snapshot
                10.9.2.    Overview
                10.9.3.    Offerings
                10.9.4.    Financial Insight
                10.9.5.    Recent Developments
        10.10. Trivitron Healthcare
                10.10.1. Snapshot
                10.10.2. Overview
                10.10.3. Offerings
                10.10.4. Financial Insight
                10.10.5. Recent Developments

11.    Appendix

        11.1.    Exchange Rates
        11.2.    Abbreviations

Note: Financial insight and recent developments of different companies are subject to the availability of information in the secondary domain.

List of Tables

Table 1 Sources
Table 2 Study Periods
Table 3 Data Reporting Unit
Table 4 Global Media Contrast Market Size, By Media Type, 2018-2021 (USD Billion)
Table 5 Global Media Contrast Market Size, By Media Type, 2022-2030 (USD Billion)
Table 6 Global Media Contrast Market Size, By Indication, 2018-2021 (USD Billion)
Table 7 Global Media Contrast Market Size, By Indication, 2022-2030 (USD Billion)
Table 8 Global Media Contrast Market Size, By Modality, 2018-2021 (USD Billion)
Table 9 Global Media Contrast Market Size, By Modality, 2022-2030 (USD Billion)
Table 10 Global Media Contrast Market Size, By Route of Administration, 2018-2021 (USD Billion)
Table 11 Global Media Contrast Market Size, By Route of Administration, 2022-2030 (USD Billion)
Table 12 Global Media Contrast Market Size, By Application, 2018-2021 (USD Billion)
Table 13 Global Media Contrast Market Size, By Application, 2022-2030 (USD Billion)
Table 14 Global Media Contrast Market Size, by Region, 2018-2021 (USD Billion)
Table 15 Global Media Contrast Market Size, by Region, 2022-2030 (USD Billion)
Table 16 North America Media Contrast Market Size, By Media Type, 2018-2021 (USD Billion)
Table 17 North America Media Contrast Market Size, By Media Type, 2022-2030 (USD Billion)
Table 18 North America Media Contrast Market Size, By Indication, 2018-2021 (USD Billion)
Table 19 North America Media Contrast Market Size, By Indication, 2022-2030 (USD Billion)
Table 20 North America Media Contrast Market Size, By Modality, 2018-2021 (USD Billion)
Table 21 North America Media Contrast Market Size, By Modality, 2022-2030 (USD Billion)
Table 22 North America Media Contrast Market Size, By Route of Administration, 2018-2021 (USD Billion)
Table 23 North America Media Contrast Market Size, By Route of Administration, 2022-2030 (USD Billion)
Table 24 North America Media Contrast Market Size, By Application, 2018-2021 (USD Billion)
Table 25 North America Media Contrast Market Size, By Application, 2022-2030 (USD Billion)
Table 26 North America Media Contrast Market Size, by Region, 2018-2021 (USD Billion)
Table 27 North America Media Contrast Market Size, by Region, 2022-2030 (USD Billion)
Table 28 Europe Media Contrast Market Size, By Media Type, 2018-2021 (USD Billion)
Table 29 Europe Media Contrast Market Size, By Media Type, 2022-2030 (USD Billion)
Table 30 Europe Media Contrast Market Size, By Indication, 2018-2021 (USD Billion)
Table 31 Europe Media Contrast Market Size, By Indication, 2022-2030 (USD Billion)
Table 32 Europe Media Contrast Market Size, By Modality, 2018-2021 (USD Billion)
Table 33 Europe Media Contrast Market Size, By Modality, 2022-2030 (USD Billion)
Table 34 Europe Media Contrast Market Size, By Route of Administration, 2018-2021 (USD Billion)
Table 35 Europe Media Contrast Market Size, By Route of Administration, 2022-2030 (USD Billion)
Table 36 Europe Media Contrast Market Size, By Application, 2018-2021 (USD Billion)
Table 37 Europe Media Contrast Market Size, By Application, 2022-2030 (USD Billion)
Table 38 Europe Media Contrast Market Size, by Region, 2018-2021 (USD Billion)
Table 39 Europe Media Contrast Market Size, by Region, 2022-2030 (USD Billion)
Table 40 Asia-Pacific Media Contrast Market Size, By Media Type, 2018-2021 (USD Billion)
Table 41 Asia-Pacific Media Contrast Market Size, By Media Type, 2022-2030 (USD Billion)
Table 42 Asia-Pacific Media Contrast Market Size, By Indication, 2018-2021 (USD Billion)
Table 43 Asia-Pacific Media Contrast Market Size, By Indication, 2022-2030 (USD Billion)
Table 44 Asia-Pacific Media Contrast Market Size, By Modality, 2018-2021 (USD Billion)
Table 45 Asia-Pacific Media Contrast Market Size, By Modality, 2022-2030 (USD Billion)
Table 46 Asia-Pacific Media Contrast Market Size, By Route of Administration, 2018-2021 (USD Billion)
Table 47 Asia-Pacific Media Contrast Market Size, By Route of Administration, 2022-2030 (USD Billion)
Table 48 Asia-Pacific Media Contrast Market Size, By Application, 2018-2021 (USD Billion)
Table 49 Asia-Pacific Media Contrast Market Size, By Application, 2022-2030 (USD Billion)
Table 50 Asia-Pacific Media Contrast Market Size, by Region, 2018-2021 (USD Billion)
Table 51 Asia-Pacific Media Contrast Market Size, by Region, 2022-2030 (USD Billion)
Table 52 RoW Media Contrast Market Size, By Media Type, 2018-2021 (USD Billion)
Table 53 RoW Media Contrast Market Size, By Media Type, 2022-2030 (USD Billion)
Table 54 RoW Media Contrast Market Size, By Indication, 2018-2021 (USD Billion)
Table 55 RoW Media Contrast Market Size, By Indication, 2022-2030 (USD Billion)
Table 56 RoW Media Contrast Market Size, By Modality, 2018-2021 (USD Billion)
Table 57 RoW Media Contrast Market Size, By Modality, 2022-2030 (USD Billion)
Table 58 RoW Media Contrast Market Size, By Route of Administration, 2018-2021 (USD Billion)
Table 59 RoW Media Contrast Market Size, By Route of Administration, 2022-2030 (USD Billion)
Table 60 RoW Media Contrast Market Size, By Application, 2018-2021 (USD Billion)
Table 61 RoW Media Contrast Market Size, By Application, 2022-2030 (USD Billion)
Table 62 RoW Media Contrast Market Size, by Region, 2018-2021 (USD Billion)
Table 63 RoW Media Contrast Market Size, by Region, 2022-2030 (USD Billion)
Table 64 Snapshot – GE HealthCare
Table 65 Snapshot – Bracco
Table 66 Snapshot – Bayer AG
Table 67 Snapshot – Guerbet
Table 68 Snapshot – DAIICHI SANKYO COMPANY, LIMITED
Table 69 Snapshot – Lantheus
Table 70 Snapshot – TAEJOON PHARM
Table 71 Snapshot – Magnus Health
Table 72 Snapshot – Nano THERAPEUTICS PVT.LTD.
Table 73 Snapshot – Trivitron Healthcare

List of Figures

Figure 1 Market Coverage
Figure 2 Research Phases
Figure 3 Secondary Sources for Different Parameters
Figure 4 Methodology
Figure 5 Data Mining & Exploration
Figure 6 Data Triangulation
Figure 7 Assumptions for Market Estimation and Forecast
Figure 8 Market Synopsis
Figure 9 Global Media Contrast Market - Growth Drivers and Restraints
Figure 10 Competitive Benchmark
Figure 11 Global Media Contrast Market Highlight
Figure 12 Global Media Contrast Market Size, By Media Type, 2018-2021 (USD Billion)
Figure 13 Global Media Contrast Market Size, By Indication, 2018-2021 (USD Billion)
Figure 14 Global Media Contrast Market Size, By Modality, 2018-2021 (USD Billion)
Figure 15 Global Media Contrast Market Size, By Route of Administration, 2018-2021 (USD Billion)
Figure 16 Global Media Contrast Market Size, By Application, 2018-2021 (USD Billion)
Figure 17 Global Media Contrast Market Size, by Region, 2018-2021 (USD Billion)
Figure 18 North America Media Contrast Market Highlight
Figure 19 North America Media Contrast Market Size, By Media Type, 2018-2030 (USD Billion)
Figure 20 North America Media Contrast Market Size, By Indication, 2018-2030 (USD Billion)
Figure 21 North America Media Contrast Market Size, By Modality, 2018-2030 (USD Billion)
Figure 22 North America Media Contrast Market Size, By Route of Administration, 2018-2030 (USD Billion)
Figure 23 North America Media Contrast Market Size, By Application, 2018-2030 (USD Billion)
Figure 24 North America Media Contrast Market Size, by Region, 2018-2030 (USD Billion)
Figure 25 Europe Media Contrast Market Highlight
Figure 26 Europe Media Contrast Market Size, By Media Type, 2018-2030 (USD Billion)
Figure 27 Europe Media Contrast Market Size, By Indication, 2018-2030 (USD Billion)
Figure 28 Europe Media Contrast Market Size, By Modality, 2018-2030 (USD Billion)
Figure 29 Europe Media Contrast Market Size, By Route of Administration, 2018-2030 (USD Billion)
Figure 30 Europe Media Contrast Market Size, By Application, 2018-2030 (USD Billion)
Figure 31 Europe Media Contrast Market Size, by Region, 2018-2030 (USD Billion)
Figure 32 Asia-Pacific Media Contrast Market Highlight
Figure 33 Asia-Pacific Media Contrast Market Size, By Media Type, 2018-2030 (USD Billion)
Figure 34 Asia-Pacific Media Contrast Market Size, By Indication, 2018-2030 (USD Billion)
Figure 35 Asia-Pacific Media Contrast Market Size, By Modality, 2018-2030 (USD Billion)
Figure 36 Asia-Pacific Media Contrast Market Size, By Route of Administration, 2018-2030 (USD Billion)
Figure 37 Asia-Pacific Media Contrast Market Size, By Application, 2018-2030 (USD Billion)
Figure 38 Asia-Pacific Media Contrast Market Size, by Region, 2018-2030 (USD Billion)
Figure 39 RoW Media Contrast Market Highlight
Figure 40 RoW Media Contrast Market Size, By Media Type, 2018-2030 (USD Billion)
Figure 41 RoW Media Contrast Market Size, By Indication, 2018-2030 (USD Billion)
Figure 42 RoW Media Contrast Market Size, By Modality, 2018-2030 (USD Billion)
Figure 43 RoW Media Contrast Market Size, By Route of Administration, 2018-2030 (USD Billion)
Figure 44 RoW Media Contrast Market Size, By Application, 2018-2030 (USD Billion)
Figure 45 RoW Media Contrast Market Size, by Region, 2018-2030 (USD Billion)